Canada· CA-DIN-02327848
NEUROLITE
A central nervous system product containing bicisate dihydrochloride, registered in Canada by LANTHEUS MI CANADA INC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- BICISATE DIHYDROCHLORIDE
- Manufacturer
- LANTHEUS MI CANADA INC
- Country
- Canada (CA)
- ATC code
- V09A
- ATC class
- CENTRAL NERVOUS SYSTEM
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bicisate dihydrochloride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNeuroliteLantheus EU
- FinlandNeuroliteLantheus MI UK Limited
- FranceNEUROLITE, trousse pour la préparation radiopharmaceutique : Injection de Bicisate de Technétium (99mTc)LANTHEUS EU (IRLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Belgium · Neurolite
- Luxembourg · Neurolite
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ddbbdfe-e85f-4b7f-80a1-c69f2ab51e72 GET /v1/drugs/0ddbbdfe-e85f-4b7f-80a1-c69f2ab51e72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02327848",
"form": "KIT",
"class": "Radiopharmaceutical",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V09A",
"schedule": [
"Schedule C"
],
"drug_code": "81334",
"strengths": [
"0.9 MG"
],
"ahfs_class": null,
"substances": [
"BICISATE DIHYDROCHLORIDE"
],
"product_categorization": null
}See everything about bicisate dihydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.